Finance

Lists
002826:SHE
Tibet Aim Pharm Inc
CNÂ¥16,74
-0,89%
(-0,15) 1D
14 Okt., 15:04:18 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002826...
Open
CNÂ¥16,91
High
CNÂ¥16,98
Low
CNÂ¥16,53
Mkt. cap
3,22 mjd
Avg. vol.
3,54 m
Volume
1,96 m
Dividend
0,90%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
09 Jun. 2026
P/E ratio
25,72
52-wk high
CNÂ¥23,19
52-wk low
CNÂ¥14,65
EPS
CNÂ¥0,65
Shares outstanding
190,68 m
No. of employees
405
Open
CNÂ¥16,91
High
CNÂ¥16,98
Low
CNÂ¥16,53
Mkt. cap
3,22 mjd
Avg. vol.
3,54 m
Volume
1,96 m
Dividend
0,90%
Quarterly dividend
CNÂ¥0,04
Ex-dividend date
09 Jun. 2026
P/E ratio
25,72
52-wk high
CNÂ¥23,19
52-wk low
CNÂ¥14,65
EPS
CNÂ¥0,65
Shares outstanding
190,68 m
No. of employees
405
News stories
From web sources and news partners
About Tibet Aim Pharm Inc
CEO-
Employees405
Founded2003
Headquarters-
SectorPharmaceutical industry
Websiteemyy.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
177,54 m
147,29 m
182,58 m
177,05 m
Cost of goods sold
27,76 m
26,53 m
31,99 m
32,66 m
Cost of revenue
27,76 m
26,53 m
31,99 m
32,66 m
Research and development expenses
7,64 m
4,79 m
599,92 k
1,18 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
120,14 m
104,13 m
122,41 m
111,42 m
Operating expense
96,19 m
143,90 m
126,22 m
115,86 m
Total operating expenses
123,95 m
170,43 m
158,21 m
148,52 m
Operating income
53,59 m
-23,14 m
24,37 m
28,53 m
Other non operating income
-13,92 k
821,38 k
228,21 k
212,08 k
EBT including unusual items
53,05 m
11,45 m
24,91 m
58,11 m
EBT excluding unusual items
53,97 m
-21,21 m
24,97 m
30,45 m
Income tax expense
9,03 m
91,36 k
5,26 m
11,08 m
Effective tax rate
17,02%
0,80%
21,12%
19,06%
Other operating expenses
-31,68 m
36,59 m
2,79 m
3,24 m
Net income
44,21 m
10,82 m
19,65 m
47,03 m
Net profit margin
24,90%
7,34%
10,76%
26,56%
Earnings per share
-
-
-
-
Interest and investment income
704,13 k
1,26 m
402,27 k
1,79 m
Interest expense
-310,24 k
-158,84 k
-27,52 k
-89,35 k
Net interest expenses
393,89 k
1,10 m
374,75 k
1,70 m
Depreciation and amortization charges
-
-
-
-
EBITDA
58,98 m
-18,39 m
29,12 m
32,74 m
Gain or loss from assets sale
-231,28 k
231,32 k
-
87,49 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme